DILTIAZEM RESINATE

Diltiazem resinate is a sustained-release calcium channel blocker reducing cardiac workload and vascular resistance. Used in hypertension and angina. Side effects include edema, dizziness, and bradycardia. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 9ef30313dc11 Category: Tag:

Product Description


Mechanism of Action

Diltiazem resinate is a resinbound, sustainedrelease form of the calciumchannel blocker diltiazem. It inhibits Ltype calcium channels in cardiac and smooth muscle cells, reducing contractility, slowing AVnode conduction, and lowering peripheral resistance. The resinate matrix provides controlled release and improved stability.

Benefits and Advantages

Used in calciumchannel research, antiarrhythmic modelling, controlledrelease formulation studies, and cardiovascular pharmacodynamics.

Side Effects and Risks

Risks include bradycardia, hypotension, edema, AV block and dizziness. Handle with cardioactivecalciumchannelblocker precautions.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C22H26N2O4S·resin

Molecular Weight

414.5 g/mol

CAS Number

42399-41-7

Storage Condition

Store in a cool, dry place; protect from light

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

Synonym

34933-06-7; 3-Acetoxy-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one; RefChem:1066966; 252-295-2; 3-(Acetyloxy)-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one

IUPAC/Chemical Name

Diltiazem resin salt

InChl Key

Unavailable

InChl Code

Unavailable

References

PubChem; ChemBL; FDA;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download